Please assess the completion status of the following clinical trial:

Trial Title: Antireflux Efficacy of Hiatal Hernia Repairs in Sleeve Gastrectomy Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* All obese patients with a BMI between 35-50~* Aged 18-65 and undergoing surgery for a Sleeve Gastrectomy in institution's bariatric surgery department~Exclusion Criteria:~* hiatal hernias greater than 2 cm,~* hiatal repair requiring mesh placement~* prior bariatric surgery or any other counterindication to Sleeve Gastrectomy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Sleeve Gastrectomy group (Type: ACTIVE_COMPARATOR): This group will receive a Sleeve Gastrectomy only, a mainly restrictive procedure which consists in creating a narrow tube-like stomach based on its lesser curvature.
- Sleeve Gastrectomy + Hiatal Hernia repair group (Type: EXPERIMENTAL): This group will receive a Sleeve Gastrectomy combined with hiatal hernia repair. Hiatal Hernia repair consists of a peri-esophageal dissection proximal to the diaphragmatic crura to achieve an intra-abdominal esophageal length of 2-3 cm. The pillars will then be closed anteriorly and posteriorly using nonabsorbable sutures.

Based on this trial design, predict the completion outcome and termination type (if applicable).